3 results
Approved WMOCompleted
To increase progression-free survival at 3 months.
Approved WMOCompleted
The purpose of this pilot-trial is the feasibility of a large randomized, placebo controlled, dubbleblind clinical trial to investigate the use of methylfenidate, rivastigmine or haloperidol in hypoactive ICU-delirium. Secondary we will try to…
Approved WMORecruiting
The aim of this study is to examine the effectiveness of treatment with tDCS in reducing AVH and related symptoms in patients with BPD and AVH